Michael S. Perry, Director at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 7,128 shares at $65.12 ($460K) on 2022-01-03, disclosed to the SEC on 2022-01-04.
Seasonal sale ($460k) by Director — this insider has traded ARWR in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.30 | 2,628 | $169K | 36.7% |
| 2 | $64.30 | 2,628 | $169K | 36.7% |
| 3 | $65.12 | 1,600 | $104K | 22.6% |
| 4 | $66.25 | 272 | $18K | 3.9% |
| Total | $64.56 avg | 7,128 | $460K | 100% |
| Filing → |
| RCEL | SELL | 2022-11-22 | $1.1M | — | Filing → |
| RCEL | SELL | 2022-02-25 | $189K | — | Filing → |
| RCEL | SELL | 2021-09-07 | $464K | — | Filing → |